» Articles » PMID: 32008623

Lung Cancer 2020: Epidemiology, Etiology, and Prevention

Overview
Journal Clin Chest Med
Specialty Pulmonary Medicine
Date 2020 Feb 4
PMID 32008623
Citations 790
Authors
Affiliations
Soon will be listed here.
Abstract

Despite advances in our understanding of risk, development, immunologic control, and treatment options for lung cancer, it remains the leading cause of cancer death. Tobacco smoking remains the predominant risk factor for lung cancer development. Nontobacco risk factors include environmental and occupational exposures, chronic lung disease, lung infections, and lifestyle factors. Because tobacco remains the leading risk factor for lung cancer, disease prevention is focused on smoking avoidance and cessation. Other prevention measures include healthy diet choices and maintaining a physically active lifestyle. Future work should focus on smoking cessation campaigns and better understanding disease development and treatment strategies in nonsmokers.

Citing Articles

Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of lung cancer biomarkers.

Li Y, Tong Z, Yang Y, Wang Y, Wen L, Li Y BMC Cancer. 2025; 25(1):478.

PMID: 40089661 DOI: 10.1186/s12885-025-13883-w.


Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment.

Rostami Ravari N, Sadri F, Mahdiabadi M, Mohammadi Y, Ourang Z, Rezaei Z Front Cell Dev Biol. 2025; 13:1522873.

PMID: 40078365 PMC: 11897296. DOI: 10.3389/fcell.2025.1522873.


Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature).

Smolarz B, Lukasiewicz H, Samulak D, Piekarska E, Kolacinski R, Romanowicz H Int J Mol Sci. 2025; 26(5).

PMID: 40076671 PMC: 11900952. DOI: 10.3390/ijms26052049.


Robust vs. Non-robust radiomic features: the quest for optimal machine learning models using phantom and clinical studies.

Hosseini S, Hajianfar G, Hall B, Servaes S, Rosa-Neto P, Ghafarian P Cancer Imaging. 2025; 25(1):33.

PMID: 40075547 PMC: 11905451. DOI: 10.1186/s40644-025-00857-1.


The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma.

Xu C, Liu M, Li Y, Peng X, Zhou W, Zhang W Discov Oncol. 2025; 16(1):270.

PMID: 40050481 PMC: 11885760. DOI: 10.1007/s12672-025-01986-6.